FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000893535> ?p ?o ?g. }

• W2000893535 endingPage "14484" @default.
• W2000893535 startingPage "14479" @default.
• W2000893535 abstract "Human stem cell leukemia-lymphoma syndrome usually presents itself as a myeloproliferative disorder (MPD) that evolves to acute myeloid leukemia and/or lymphoma. The syndrome associated with t(8;13)(p11;q12) results in expression of the ZNF198-fibroblast growth factor receptor (FGFR) 1 fusion tyrosine kinase. Current empirically derived cytotoxic chemotherapy is inadequate for treatment of this disease. We hypothesized that small-molecule inhibitors of the ZNF198-FGFR1 fusion would have therapeutic efficacy. We characterized the transforming activity of ZNF198-FGFR1 in hematopoietic cells in vitro and in vivo . Expression of ZNF198-FGFR1 in primary murine hematopoietic cells caused a myeloproliferative syndrome in mice that recapitulated the human MPD phenotype. Transformation in these assays, and activation of the downstream effector molecules PLC-γ, STAT5, and phosphatidylinositol 3-kinase/AKT, required the proline-rich domains, but not the ZNF domains, of ZNF198. A small-molecule tyrosine kinase inhibitor, PKC412 ( N -benzoyl-staurosporine) effectively inhibited ZNF198-FGFR1 tyrosine kinase activity and activation of downstream effector pathways, and inhibited proliferation of ZNF198-FGFR1 transformed Ba/F3 cells. Furthermore, treatment with PKC412 resulted in statistically significant prolongation of survival in the murine model of ZNF198-FGFR1-induced MPD. Based in part on these data, PKC412 was administered to a patient with t(8;13)(p11;q12) and was efficacious in treatment of progressive myeloproliferative disorder with organomegaly. Therefore, PKC412 may be a useful therapy for treatment of human stem cell leukemia-lymphoma syndrome." @default.
• W2000893535 created "2016-06-24" @default.
• W2000893535 creator A5005876566 @default.
• W2000893535 creator A5006031821 @default.
• W2000893535 creator A5010346310 @default.
• W2000893535 creator A5011479527 @default.
• W2000893535 creator A5027429869 @default.
• W2000893535 creator A5033968338 @default.
• W2000893535 creator A5034862855 @default.
• W2000893535 creator A5039503690 @default.
• W2000893535 creator A5040359760 @default.
• W2000893535 creator A5042060039 @default.
• W2000893535 creator A5047939331 @default.
• W2000893535 creator A5048379858 @default.
• W2000893535 creator A5048380473 @default.
• W2000893535 creator A5051795460 @default.
• W2000893535 creator A5053373947 @default.
• W2000893535 creator A5063007183 @default.
• W2000893535 creator A5065807262 @default.
• W2000893535 creator A5066220779 @default.
• W2000893535 creator A5071023119 @default.
• W2000893535 creator A5074658394 @default.
• W2000893535 creator A5082924494 @default.
• W2000893535 creator A5083102463 @default.
• W2000893535 creator A5090097432 @default.
• W2000893535 date "2004-09-24" @default.
• W2000893535 modified "2023-10-06" @default.
• W2000893535 title "PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder" @default.
• W2000893535 cites W11727989 @default.
• W2000893535 cites W1255933066 @default.
• W2000893535 cites W1498616452 @default.
• W2000893535 cites W1506206499 @default.
• W2000893535 cites W1571014830 @default.
• W2000893535 cites W1580588005 @default.
• W2000893535 cites W1963557114 @default.
• W2000893535 cites W1973378655 @default.
• W2000893535 cites W1983999811 @default.
• W2000893535 cites W1995950669 @default.
• W2000893535 cites W1996188067 @default.
• W2000893535 cites W1996987411 @default.
• W2000893535 cites W2012660359 @default.
• W2000893535 cites W2015015957 @default.
• W2000893535 cites W2016396075 @default.
• W2000893535 cites W2029508452 @default.
• W2000893535 cites W2064698668 @default.
• W2000893535 cites W2066913808 @default.
• W2000893535 cites W2069057374 @default.
• W2000893535 cites W2075428599 @default.
• W2000893535 cites W2095509444 @default.
• W2000893535 cites W2097840856 @default.
• W2000893535 cites W2126524003 @default.
• W2000893535 cites W2127593405 @default.
• W2000893535 cites W2130934958 @default.
• W2000893535 cites W2146897170 @default.
• W2000893535 cites W2156568059 @default.
• W2000893535 cites W2168117739 @default.
• W2000893535 cites W2408425267 @default.
• W2000893535 cites W4232525994 @default.
• W2000893535 cites W4250180674 @default.
• W2000893535 cites W4255330185 @default.
• W2000893535 doi "https://doi.org/10.1073/pnas.0404438101" @default.
• W2000893535 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/521956" @default.
• W2000893535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15448205" @default.
• W2000893535 hasPublicationYear "2004" @default.
• W2000893535 type Work @default.
• W2000893535 sameAs 2000893535 @default.
• W2000893535 citedByCount "156" @default.
• W2000893535 countsByYear W20008935352012 @default.
• W2000893535 countsByYear W20008935352013 @default.
• W2000893535 countsByYear W20008935352014 @default.
• W2000893535 countsByYear W20008935352015 @default.
• W2000893535 countsByYear W20008935352016 @default.
• W2000893535 countsByYear W20008935352017 @default.
• W2000893535 countsByYear W20008935352018 @default.
• W2000893535 countsByYear W20008935352019 @default.
• W2000893535 countsByYear W20008935352020 @default.
• W2000893535 countsByYear W20008935352021 @default.
• W2000893535 countsByYear W20008935352022 @default.
• W2000893535 countsByYear W20008935352023 @default.
• W2000893535 crossrefType "journal-article" @default.
• W2000893535 hasAuthorship W2000893535A5005876566 @default.
• W2000893535 hasAuthorship W2000893535A5006031821 @default.
• W2000893535 hasAuthorship W2000893535A5010346310 @default.
• W2000893535 hasAuthorship W2000893535A5011479527 @default.
• W2000893535 hasAuthorship W2000893535A5027429869 @default.
• W2000893535 hasAuthorship W2000893535A5033968338 @default.
• W2000893535 hasAuthorship W2000893535A5034862855 @default.
• W2000893535 hasAuthorship W2000893535A5039503690 @default.
• W2000893535 hasAuthorship W2000893535A5040359760 @default.
• W2000893535 hasAuthorship W2000893535A5042060039 @default.
• W2000893535 hasAuthorship W2000893535A5047939331 @default.
• W2000893535 hasAuthorship W2000893535A5048379858 @default.
• W2000893535 hasAuthorship W2000893535A5048380473 @default.
• W2000893535 hasAuthorship W2000893535A5051795460 @default.
• W2000893535 hasAuthorship W2000893535A5053373947 @default.
• W2000893535 hasAuthorship W2000893535A5063007183 @default.
• W2000893535 hasAuthorship W2000893535A5065807262 @default.
• W2000893535 hasAuthorship W2000893535A5066220779 @default.

• next